리타바제 및 라피리신(레테플라제) 시장 보고서(2025년) : 역학, 파이프라인 분석, 시장 인사이트 및 예측

Retavase, also known as rapilysin, is a recombinant tissue plasminogen activator (rtPA) used in the treatment of acute myocardial infarction (heart attack). It works by dissolving blood clots that block coronary arteries, helping to restore blood flow to the heart muscle.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary forms in the retavase or papilysin (reteplase) market are powder and solution. The lyophilized powder form of reteplase, used in Retavase, is reconstituted with sterile water to create an injectable solution for dissolving blood clots in heart attack treatment. Its clinical indications include acute ST-elevation myocardial infarction and acute ischemic stroke, with applications in hospitals, clinics, and other settings. Distribution channels include hospital pharmacies, online pharmacies, and retail pharmacies.

The retavase or rapilysin (reteplase) market research report is one of a series of new reports from The Business Research Company that provides retavase or rapilysin (reteplase) market statistics, including retavase or rapilysin (reteplase) industry global market size, regional shares, competitors with a retavase or rapilysin (reteplase) market share, detailed Retavase or Rapilysin (reteplase) market segments, market trends, and opportunities, and any further data you may need to thrive in the retavase or rapilysin (reteplase) industry. This retavase or rapilysin (reteplase) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The retavase/rapilysin (reteplase) market size is expected to see exponential growth in the next few years. It will grow to $1,535.1 million in 2029 at a compound annual growth rate (CAGR) of 22%. The growth in the forecast period can be attributed to growing incidence of cardiovascular diseases, aging global population, emerging markets adoption, advances in personalized medicine, continued innovations in drug delivery systems. Major trends in the forecast period include increased use of thrombolytic therapy in pre-hospital settings, integration of artificial intelligence in cardiac care, rise in combination therapies, focus on cost-effective treatments, telemedicine and remote patient monitoring.

The rising incidence of cardiovascular diseases (CVDs) is expected to drive the growth of the retavase or rapilysin (reteplase) market. CVDs, including coronary artery disease, heart failure, stroke, and heart attacks, are becoming more prevalent due to factors such as aging populations, unhealthy diets, sedentary lifestyles, and smoking. Retavase (Reteplase) is used to treat conditions like acute myocardial infarction (heart attacks) by breaking down blood clots blocking coronary arteries, restoring blood flow to the heart, and preventing further heart damage. For example, in July 2024, Eurostat reported high rates of heart bypass and coronary angioplasty procedures in Cyprus and Croatia, indicating a rising need for effective treatments like retavase. Therefore, the growing incidence of cardiovascular diseases is a key driver for the market.

The increasing aging population is also expected to propel the growth of the retavase/rapilysin (reteplase) market. The aging population, driven by increased life expectancy and lower birth rates, is more susceptible to cardiovascular complications. Retavase (Reteplase) is effective in treating blood clots in elderly patients suffering from acute myocardial infarction, helping to reduce mortality and improve recovery outcomes. In July 2024, UK government statistics showed that 19% of the UK population was aged 65 or older in 2022, with projections indicating that this proportion will rise to 27% by 2072. This demographic shift will likely increase demand for cardiovascular treatments like Retavase, driving market growth.

The increasing research investments are expected to support the growth of the retavase/rapilysin (reteplase) market. Research investments aim to develop more effective and targeted therapies for cardiovascular conditions. Increased funding for scientific and technological advancements helps improve the formulation of treatments like Retavase and expand their clinical applications. For instance, in August 2023, Eurostat reported a 5.4% rise in research and development funding across Europe, totaling approximately $126 billion in 2022. These investments are crucial in enhancing treatment options, thus driving the market for retavase or rapilysin (reteplase).

Major players operating in the retavase or rapilysin (reteplase) market are Chiesi Farmaceutici S.p.A., Wacker Biotech GmbH.

North America was the largest region in the retavase or rapilysin (reteplase) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in retavase or rapilysin (reteplase) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the retavase or rapilysin (reteplase) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The retavase or rapilysin (reteplase) market consists of sales of combination thrombolytic therapy products, pre-filled syringes or ready-to-use kits, and diagnostic and monitoring equipment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Retavase Or Rapilysin (reteplase) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on retavase or rapilysin (reteplase) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-4 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for retavase or rapilysin (reteplase) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The retavase or rapilysin (reteplase) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Powder; Solution
• 2) By Clinical Indication: Acute ST-Elevation Myocardial Infarction; Acute Ischemic Stroke
• 3) By Application: Hospital; Clinic; Other Applications
• 4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
• Companies Mentioned: Chiesi Farmaceutici S.p.A.; Wacker Biotech GmbH
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Retavase Or Rapilysin (reteplase) Market Characteristics

3. Retavase Or Rapilysin (reteplase) Market Biologic Drug Characteristics

• 3.1. Molecule Type
• 3.2. Route Of Administration (ROA)
• 3.3. Mechanism Of Action (MOA)
• 3.4. Safety And Efficacy

4. Retavase Or Rapilysin (reteplase) Market Trends And Strategies

5. Retavase Or Rapilysin (reteplase) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Retavase Or Rapilysin (reteplase) Growth Analysis And Strategic Analysis Framework

• 6.1. Global Retavase Or Rapilysin (reteplase) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 6.2. Analysis Of End Use Industries
• 6.3. Global Retavase Or Rapilysin (reteplase) Market Growth Rate Analysis
• 6.4. Global Retavase Or Rapilysin (reteplase) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 6.5. Global Retavase Or Rapilysin (reteplase) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 6.6. Global Retavase Or Rapilysin (reteplase) Total Addressable Market (TAM)

7. Global Retavase Or Rapilysin (reteplase) Market Pricing Analysis & Forecasts

8. Retavase Or Rapilysin (reteplase) Market Segmentation

• 8.1. Global Retavase Or Rapilysin (reteplase) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Powder
• Solution
• 8.2. Global Retavase Or Rapilysin (reteplase) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute ST-Elevation Myocardial Infarction
• Acute Ischemic Stroke
• 8.3. Global Retavase Or Rapilysin (reteplase) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Clinic
• Other Applications
• 8.4. Global Retavase Or Rapilysin (reteplase) Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

9. Global Retavase Or Rapilysin (reteplase) Market Epidemiology Of Clinical Indications

• 9.1. Drug Side Effects
• 9.2. Incidence And Prevalence of Clinical Indications

10. Retavase Or Rapilysin (reteplase) Market Regional And Country Analysis

• 10.1. Global Retavase Or Rapilysin (reteplase) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. Global Retavase Or Rapilysin (reteplase) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Retavase Or Rapilysin (reteplase) Market

• 11.1. Asia-Pacific Retavase Or Rapilysin (reteplase) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Retavase Or Rapilysin (reteplase) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Asia-Pacific Retavase Or Rapilysin (reteplase) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Asia-Pacific Retavase Or Rapilysin (reteplase) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Retavase Or Rapilysin (reteplase) Market

• 12.1. China Retavase Or Rapilysin (reteplase) Market Overview
• 12.2. China Retavase Or Rapilysin (reteplase) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.3. China Retavase Or Rapilysin (reteplase) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 12.4. China Retavase Or Rapilysin (reteplase) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Retavase Or Rapilysin (reteplase) Market

• 13.1. India Retavase Or Rapilysin (reteplase) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. India Retavase Or Rapilysin (reteplase) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. India Retavase Or Rapilysin (reteplase) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Retavase Or Rapilysin (reteplase) Market

• 14.1. Japan Retavase Or Rapilysin (reteplase) Market Overview
• 14.2. Japan Retavase Or Rapilysin (reteplase) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. Japan Retavase Or Rapilysin (reteplase) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. Japan Retavase Or Rapilysin (reteplase) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Retavase Or Rapilysin (reteplase) Market

• 15.1. Australia Retavase Or Rapilysin (reteplase) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.2. Australia Retavase Or Rapilysin (reteplase) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Australia Retavase Or Rapilysin (reteplase) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Retavase Or Rapilysin (reteplase) Market

• 16.1. South Korea Retavase Or Rapilysin (reteplase) Market Overview
• 16.2. South Korea Retavase Or Rapilysin (reteplase) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. South Korea Retavase Or Rapilysin (reteplase) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.4. South Korea Retavase Or Rapilysin (reteplase) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Retavase Or Rapilysin (reteplase) Market

• 17.1. Western Europe Retavase Or Rapilysin (reteplase) Market Overview
• 17.2. Western Europe Retavase Or Rapilysin (reteplase) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Western Europe Retavase Or Rapilysin (reteplase) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.4. Western Europe Retavase Or Rapilysin (reteplase) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Retavase Or Rapilysin (reteplase) Market

• 18.1. UK Retavase Or Rapilysin (reteplase) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. UK Retavase Or Rapilysin (reteplase) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. UK Retavase Or Rapilysin (reteplase) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Retavase Or Rapilysin (reteplase) Market

• 19.1. Germany Retavase Or Rapilysin (reteplase) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Germany Retavase Or Rapilysin (reteplase) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Germany Retavase Or Rapilysin (reteplase) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Retavase Or Rapilysin (reteplase) Market

• 20.1. France Retavase Or Rapilysin (reteplase) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. France Retavase Or Rapilysin (reteplase) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. France Retavase Or Rapilysin (reteplase) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Retavase Or Rapilysin (reteplase) Market

• 21.1. Eastern Europe Retavase Or Rapilysin (reteplase) Market Overview
• 21.2. Eastern Europe Retavase Or Rapilysin (reteplase) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Retavase Or Rapilysin (reteplase) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Retavase Or Rapilysin (reteplase) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Retavase Or Rapilysin (reteplase) Market

• 22.1. North America Retavase Or Rapilysin (reteplase) Market Overview
• 22.2. North America Retavase Or Rapilysin (reteplase) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. North America Retavase Or Rapilysin (reteplase) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.4. North America Retavase Or Rapilysin (reteplase) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Retavase Or Rapilysin (reteplase) Market

• 23.1. USA Retavase Or Rapilysin (reteplase) Market Overview
• 23.2. USA Retavase Or Rapilysin (reteplase) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. USA Retavase Or Rapilysin (reteplase) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. USA Retavase Or Rapilysin (reteplase) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Retavase Or Rapilysin (reteplase) Market

• 24.1. Canada Retavase Or Rapilysin (reteplase) Market Overview
• 24.2. Canada Retavase Or Rapilysin (reteplase) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. Canada Retavase Or Rapilysin (reteplase) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. Canada Retavase Or Rapilysin (reteplase) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Retavase Or Rapilysin (reteplase) Market

• 25.1. South America Retavase Or Rapilysin (reteplase) Market Overview
• 25.2. South America Retavase Or Rapilysin (reteplase) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. South America Retavase Or Rapilysin (reteplase) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. South America Retavase Or Rapilysin (reteplase) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Retavase Or Rapilysin (reteplase) Market

• 26.1. Middle East Retavase Or Rapilysin (reteplase) Market Overview
• 26.2. Middle East Retavase Or Rapilysin (reteplase) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. Middle East Retavase Or Rapilysin (reteplase) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. Middle East Retavase Or Rapilysin (reteplase) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Retavase Or Rapilysin (reteplase) Market

• 27.1. Africa Retavase Or Rapilysin (reteplase) Market Overview
• 27.2. Africa Retavase Or Rapilysin (reteplase) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Africa Retavase Or Rapilysin (reteplase) Market, Segmentation By Clinical Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.4. Africa Retavase Or Rapilysin (reteplase) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Retavase Or Rapilysin (reteplase) Market Competitive Landscape And Company Profiles

• 28.1. Retavase Or Rapilysin (reteplase) Market Competitive Landscape
• 28.2. Retavase Or Rapilysin (reteplase) Market Company Profiles
  • 28.2.1. Chiesi Farmaceutici S.p.A. Overview, Products and Services, Strategy and Financial Analysis
  • 28.2.2. Wacker Biotech GmbH Overview, Products and Services, Strategy and Financial Analysis

29. Global Retavase Or Rapilysin (reteplase) Market Pipeline Analysis

• 29.1. High Level Clinic Trail Information

30. Global Retavase Or Rapilysin (reteplase) Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Retavase Or Rapilysin (reteplase) Market

32. Recent Developments In The Retavase Or Rapilysin (reteplase) Market

33. Retavase Or Rapilysin (reteplase) Market High Potential Countries, Segments and Strategies

• 33.1 Retavase Or Rapilysin (reteplase) Market In 2029 - Countries Offering Most New Opportunities
• 33.2 Retavase Or Rapilysin (reteplase) Market In 2029 - Segments Offering Most New Opportunities
• 33.3 Retavase Or Rapilysin (reteplase) Market In 2029 - Growth Strategies
  • 33.3.1 Market Trend Based Strategies
  • 33.3.2 Competitor Strategies

34. Appendix

• 34.1. Abbreviations
• 34.2. Currencies
• 34.3. Historic And Forecast Inflation Rates
• 34.4. Research Inquiries
• 34.5. The Business Research Company
• 34.6. Copyright And Disclaimer